View : 577 Download: 0
Sequential VAD (Vincristine, Adriamycin, Dexamethasone) and VTD (Bortezomib, Thalidomide, Dexamethasone) Induction Followed by High-Dose Therapy with Autologous Stem Cell Transplantation and Maintenance Treatment with Bortezomib for Newly Diagnosed Multiple Myeloma: Final Analysis of Phase II Trial
- Title
- Sequential VAD (Vincristine, Adriamycin, Dexamethasone) and VTD (Bortezomib, Thalidomide, Dexamethasone) Induction Followed by High-Dose Therapy with Autologous Stem Cell Transplantation and Maintenance Treatment with Bortezomib for Newly Diagnosed Multiple Myeloma: Final Analysis of Phase II Trial
- Authors
- Yoon, Suno-Soo; Kim, Hye Jin; Chung, Joo Seop; Eom, HyeonSeok; Jang, Jun-Ho; Kang, Hye Jin; Kim, Cheol Soo; Kim, Kihyun; Lee, Dongsoon; Lee, Jae Hoon; Lee, Junglim; Lee, Sang Jae; Min, Yoo Hong; Seong, Chu-Myong; Sohn, Sang-Kyun; Suh, Cheolwon; Won, Jong-Ho
- Ewha Authors
- 성주명
- SCOPUS Author ID
- 성주명
- Issue Date
- 2008
- Journal Title
- BLOOD
- ISSN
- 0006-4971
- Citation
- BLOOD vol. 112, no. 11, pp. 1144 - 1144
- Publisher
- AMER SOC HEMATOLOGY
- Indexed
- SCI; SCIE; SCOPUS
- Document Type
- Meeting Abstract
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML